Letter to Shareholders re CEO

28/09/2022

Our Letter to Shareholders regarding ORIL’s CEO is available to download.

News

Address

Registered Office
Oncology Research International Limited
Level 5, 45 St George Terrace,
Perth WA 6000 Australia

Links